The targets of these miRNAs included (i) cell growth-related genes namely proto-oncogene HMGA2, cancer stem cell marker LIN28B, and MAP Kinase-related genes RBAK and RGS17; (ii) BCL2-related genes BNIP2 and BAG1; (iii) ubiquitin-related genes TRIM71 and USP44; and (iv) transcription factors ARID3B, POU2F2, and NR6A1 (Table 4). The gene discussed is RBAK; the disease is cancer.